FGF23 and hydrops fetalis: FGF23 rises during HF exacerbations, associates with disease severity, and predicts risk of HF-related death and hospitalization, as well as likelihood of therapeutic response to angiotensin-converting enzyme inhibitor (ACE inhibitor) therapy irrespective of kidney function6–9.